Compare KW & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KW | PRGO |
|---|---|---|
| Founded | 1977 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2007 | 2013 |
| Metric | KW | PRGO |
|---|---|---|
| Price | $11.02 | $10.76 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $11.00 | ★ $19.33 |
| AVG Volume (30 Days) | 1.0M | ★ 2.4M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | 4.41% | ★ 10.28% |
| EPS Growth | ★ 50.00 | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $62,633,000.00 | $800,000.00 |
| Revenue This Year | $81.79 | N/A |
| Revenue Next Year | N/A | $1.02 |
| P/E Ratio | $110.00 | ★ N/A |
| Revenue Growth | ★ 23.94 | N/A |
| 52 Week Low | $6.48 | $9.23 |
| 52 Week High | $11.09 | $28.44 |
| Indicator | KW | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 56.55 | 45.86 |
| Support Level | $10.82 | $10.46 |
| Resistance Level | $11.09 | $12.36 |
| Average True Range (ATR) | 0.03 | 0.45 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 50.00 | 41.24 |
Kennedy-Wilson Holdings Inc is a real estate investment company that owns, operates, and invests in real estate both on its own and through its investment management platform. The Company focuses on multifamily and office properties, as well as industrial and debt investments. It has two business segments; the Consolidated Portfolio includes investment activities that involve ownership of multifamily units, office, retail and industrial space, and one hotel, and The Co-Investment Portfolio segment consists of investments the Company makes with partners in which it receives fees, performance allocations that it earns on its fee-bearing capital and distributions and profits from its ownership interest in the underlying operations of its co-investments.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.